Systemic effects after intravitreal injection of bevacizumab in new born rabbit eyes.

about

Systemic effects after intravitreal injection of bevacizumab in new born rabbit eyes.

Item

http://www.wikidata.org/entity/Q48018646

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Systemic effects after intravitreal injection of bevacizumab in new born rabbit eyes.

@en

Systemic effects after intravitreal injection of bevacizumab in new born rabbit eyes.

@nl

type

Item

label

Systemic effects after intravitreal injection of bevacizumab in new born rabbit eyes.

@en

Systemic effects after intravitreal injection of bevacizumab in new born rabbit eyes.

@nl

prefLabel

Systemic effects after intravitreal injection of bevacizumab in new born rabbit eyes.

@en

Systemic effects after intravitreal injection of bevacizumab in new born rabbit eyes.

@nl

P1476

Systemic effects after intravitreal injection of bevacizumab in new born rabbit eyes.

@en

P2093

Chi-Chun Lai

http://www.w3.org/2001/XMLSchema#string

Chi-Hsien Liu

http://www.w3.org/2001/XMLSchema#string

Chih-Shan Chen

http://www.w3.org/2001/XMLSchema#string

Kwan-Jen Chen

http://www.w3.org/2001/XMLSchema#string

Tun-Lu Chen

http://www.w3.org/2001/XMLSchema#string

Wei-Chi Wu

http://www.w3.org/2001/XMLSchema#string

Yen-Po Chen

http://www.w3.org/2001/XMLSchema#string

Yih-Shiou Hwang

http://www.w3.org/2001/XMLSchema#string

Yin-Cheng Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity

On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a review

Vascular endothelial growth factor is a secreted angiogenic mitogen

Vascular-specific growth factors and blood vessel formation

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Interaction between bevacizumab and murine VEGF-A: a reassessment.

Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.

Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.

P304

41-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15569527.2017.1331356

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nan-Kai Wang

P577

2017-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28614955

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab